Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial (vol 376, pg 705, 2010)

被引：0
|
作者：
Kwo, P. Y.
Lawitz, E. J.
McCone, J.
机构：
来源：
LANCET | 2010年 / 376卷 / 9748期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1224 / 1224
页数：1
相关论文
共 50 条
  • [41] Phase II study of celgosivir in combination with peginterferon alfa-2b and ribavirin in chronic hepatitis C genotype-1 non-responder patients
    Kaita, Kelly D.
    Yoshida, Eric M.
    Kunimoto, Dennis
    Anderson, Frank
    Sherman, Morris
    Marotta, Paul
    Scully, Linda J.
    Peltekian, Kevork M.
    Enns, Robert A.
    Diaz-Mitoma, Francisco
    Lee, Sam S.
    Worobetz, Lawrence
    Pankovich, Jim
    Petersen, Annkatrin
    GASTROENTEROLOGY, 2007, 132 (04) : A740 - A740
  • [42] Predictors of Sustained Virologic Response Among Treatment-NaiVE Patients With Hepatitis C Virus Genotype 1 When Treated With Boceprevir (Boc) Plus Peginterferon Alfa-2B-Ribavirin (PR)
    Reddy, Rajender
    Bruno, Savino
    Rossaro, Lorenzo
    Ravendhran, Natarajan
    Pauly, Mary Pat
    Boparai, Navdeep
    Sniukiene, Vilma
    Brass, Clifford A.
    Albrecht, Janice K.
    Poordad, Fred
    Jacobson, Ira M.
    GASTROENTEROLOGY, 2011, 140 (05) : S943 - S943
  • [43] Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia
    Zeuzem, S
    Buti, M
    Ferenci, P
    Sperl, J
    Horsmans, Y
    Cianciara, J
    Ibranyi, E
    Weiland, O
    Noviello, S
    Brass, C
    Albrecht, J
    JOURNAL OF HEPATOLOGY, 2006, 44 (01) : 97 - 103
  • [44] ANTIVIRAL EFFICACY OF THE NS3 PROTEASE INHIBITOR, GS-9451, NON-NUCLEOSIDE NS5b INHIBITOR, TEGOBUVIR, AND PEGYLATED INTERFERON PLUS RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HEPATITIS C INFECTED PATIENTS
    Pol, S.
    Jablkowski, M.
    Trenkle, J. D.
    Kanwar, B.
    Bekele, B. N.
    Subramanian, M.
    McHutchison, J. G.
    Flamm, S. L.
    Muir, A. J.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S31 - S31
  • [45] Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naive patients with genotype 1, chronic hepatitis C
    Neumann, Avidan U.
    Pianko, Stephen
    Zeuzem, Stefan
    Yoshida, Eric M.
    Benhamou, Yves
    Mishan, Moshe
    McHutchison, John G.
    Pulkstenis, Erik
    Subramanian, G. Mani
    JOURNAL OF HEPATOLOGY, 2009, 51 (01) : 21 - 28
  • [46] Safety and Efficacy of BMS-791325, a Non-Nucleoside NS5B Polymerase Inhibitor, Combined with Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Patients Infected with Hepatitis C Virus Genotype 1
    Tatum, Harvey A.
    Thuluvath, Paul J.
    Lawitz, Eric
    Martorell, Claudia
    Cohen, Stanley M.
    Rustgi, Vinod K.
    Ravendhran, Natarajan
    Ghalib, Reem H.
    Hanson, John
    Zamparo, Joann
    Zhao, Jing
    Treitel, Michelle
    Hughes, Eric A.
    HEPATOLOGY, 2013, 58 : 759A - 760A
  • [47] Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naive or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections
    Gane, Edward J.
    Schwabe, Christian
    Hyland, Robert H.
    Yang, Yin
    Svarovskaia, Evguenia
    Stamm, Luisa M.
    Brainard, Diana M.
    McHutchison, John G.
    Stedman, Catherine A.
    GASTROENTEROLOGY, 2016, 151 (03) : 448 - +
  • [48] A RANDOMIZED TRIAL OF 24-VERSUS 48-WEEK PEGINTERFERON ALFA-2A PLUS RIBAVIRIN FOR TREATMENT-NAiVE TAIWANESE PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION
    Liu, Chen-Hua
    Liu, Chun-Jen
    Lin, Chih-Lin
    Liang, Cheng-Chao
    Hsu, Shih-Jer
    Yang, Sheng-Shun
    Hsu, Ching-Sheng
    Tseng, Tai-Chung
    Wang, Chia-Chi
    Lai, Ming-Yang
    Chen, Jun-Herng
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    HEPATOLOGY, 2008, 48 (04) : 320A - 320A
  • [49] Health-related quality of life (HRQOL) with albinterferon alfa-2b plus ribavirin in IFN Treatment-NaiVe patients with genotype 1 chronic hepatitis C
    Pianko, Stephen
    Yoshida, Eric M.
    Zeuzem, Stefan
    Benhamou, Yves
    Bain, Vincent G.
    Pulkstenis, Erik
    McHutchison, John G.
    Subramanian, Mani
    GASTROENTEROLOGY, 2008, 134 (04) : A787 - A787
  • [50] FREQUENCIES OF RESISTANCE-ASSOCIATED AMINO ACID VARIANTS FOLLOWING COMBINATION TREATMENT WITH BOCEPREVIR PLUS PEGINTRON (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C (CHC), GENOTYPE 1 (G1)
    Vierling, John M.
    Kwo, Paul Y.
    Lawitz, Eric
    McCone, Jonathan
    Schiff, Eugene R.
    Pound, David
    Davis, Mitchell
    Galati, Joseph S.
    Gordon, Stuart C.
    Ravendhran, Natarajan
    Rossaro, Lorenzo
    Anderson, Frank
    Jacobson, Ira M.
    Rubin, Raymond
    Pedicone, Lisa
    Chaudhri, Eirum I.
    Tong, Xiao
    Qiu, Ping
    Barnard, Richard J.
    Brass, Clifford A.
    Albrecht, Janice K.
    Mendez, Patricia
    Ralston, Robert
    HEPATOLOGY, 2010, 52 (04) : 702A - 703A
12345